Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...

In recent years, Artificial Intelligence (AI) has made significant strides across various sectors, providing innovative solutions and enhancing efficiency. However, ...

But three of those FDA employees told CNN that Elsa just makes up nonexistent studies, something commonly referred to in AI ...

The federal agency introduced Elsa last month, boasting about the AI tool's ability to increase efficiency at the FDA.

Hallucinations are a known problem with generative AI models—and Elsa is no different, according to Jeremy Walsh, the head of ...

FDA rushed out agency-wide AI tool—it’s not going well An agency-wide LLM called Elsa was released weeks ahead of schedule.

There’s no questioning that AI should have governance and guardrails. As much good as it can bring, it also heightens risk.

The Food and Drug Administration just announced that it will immediately start using AI across all of its centers, after completing a new generative AI pilot for scientific reviewers.. Supposedly ...

The FDA's generative AI, Elsa, has a massive hallucination problem, according to the agency's employees themselves.

FDA Commissioner Marty Makary recently hinted at the use of AI in drug reviews, saying the agency had just completed its first AI-assisted review. (Via: Wired) ...

FDA officials want to leverage AI for drug and device approval, animal testing, and data processing, as the Trump administrations slashes its workforce.

The U.S. Food and Drug Administration (FDA) has approved the first artificial intelligence (AI) tool to predict breast cancer risk. The authorization was confirmed by digital health tech company ...